Exosect welcomes Jenny Poulter to its regulatory team

May 13, 2014 - PRLog -- Winchester, UK – Exosect Ltd today announces the appointment of Jenny Poulter as Regulatory Affairs Officer.  Jenny will assist with the compilation of the Annex I dossier for Exosect’s proprietary strain of Beauveria bassiana in preparation for submission to EU regulatory authorities, planned for September this year.

Jenny has over 20 years’ regulatory experience including the regulation of veterinary medicines, genetically modified crops, crop protection products and amenity horticulture products.  Her experience includes both compilation of dossiers for industry and evaluation of dossiers by a regulatory authority.  Her previous employment includes Bayer CropScience and the Veterinary Medicines Directorate.

Ends

Notes to Editors

About Exosect

Exosect is a venture capital funded technology company. In 2001 Exosect was launched to develop proprietary platform technologies, initially for Agriculture.

The company has developed an in-depth knowledge and extensive patent portfolio of the platforms as targeted delivery mechanisms for a range of active ingredients, biological and synthetic.

Today, the technology is enabling partners across a range of sectors to realise the efficient delivery of their active ingredients.